Betmiga Description

mirabegron

Manufacturer:

Distributor:

DKSH

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each prolonged-release tablet contains 25 mg or 50 mg of mirabegron.
Excipients/Inactive Ingredients: Core tablet: Macrogols, Hydroxypropylcellulose, Butylhydroxytoluene, Magnesium stearate.
Film coating: Hypromellose, Macrogol, Iron oxide yellow (E172), Iron oxide red (E172) (25 mg only).

Exclusive offer for doctors

Already a member? Sign in